JPWO2024181455A1 - - Google Patents

Info

Publication number
JPWO2024181455A1
JPWO2024181455A1 JP2025503943A JP2025503943A JPWO2024181455A1 JP WO2024181455 A1 JPWO2024181455 A1 JP WO2024181455A1 JP 2025503943 A JP2025503943 A JP 2025503943A JP 2025503943 A JP2025503943 A JP 2025503943A JP WO2024181455 A1 JPWO2024181455 A1 JP WO2024181455A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025503943A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2024181455A1 publication Critical patent/JPWO2024181455A1/ja
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/13Labelling of peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1024Tetrapeptides with the first amino acid being heterocyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Saccharide Compounds (AREA)
JP2025503943A 2023-02-27 2024-02-27 Pending JPWO2024181455A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2023028798 2023-02-27
PCT/JP2024/007132 WO2024181455A1 (ja) 2023-02-27 2024-02-27 化合物及びこれを用いた標識生体物質

Publications (1)

Publication Number Publication Date
JPWO2024181455A1 true JPWO2024181455A1 (https=) 2024-09-06

Family

ID=92589824

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2025503943A Pending JPWO2024181455A1 (https=) 2023-02-27 2024-02-27

Country Status (5)

Country Link
US (1) US20250389724A1 (https=)
EP (1) EP4674861A1 (https=)
JP (1) JPWO2024181455A1 (https=)
CN (1) CN120752249A (https=)
WO (1) WO2024181455A1 (https=)

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001018238A1 (en) 1999-09-10 2001-03-15 Oncoimmunin, Inc. Compositions for the detection of enzyme activity in biological samples and methods of use thereof
EP0967219A4 (en) 1997-07-11 2002-09-11 Rikagaku Kenkyusho CONNECTIONS WITH ENERGY TRANSFER FUNCTION AND A METHOD FOR DNA BASE SEQUENCING USING THESE CONNECTIONS
CA2421582A1 (en) 2000-09-11 2002-03-21 The Trustees Of Columbia University In The City Of New York Combinatorial fluorescence energy transfer tags and uses thereof
CA2423806C (en) 2000-09-29 2009-12-22 Molecular Probes, Inc. Modified carbocyanine dyes and their conjugates
US20160095939A1 (en) 2014-10-07 2016-04-07 Immunomedics, Inc. Neoadjuvant use of antibody-drug conjugates
WO2010117420A2 (en) 2009-03-30 2010-10-14 Pacific Biosciences Of California, Inc. Fret-labeled compounds and uses therefor
CN104955484B (zh) * 2012-08-15 2019-01-15 文森医学公司 用于前列腺癌成像的前列腺特异性抗原药剂及其使用方法
GB201220010D0 (en) 2012-11-07 2012-12-19 Oxford Biotherapeutics Ltd Therapeutic amd diagnostic target
CN116059395A (zh) 2015-06-29 2023-05-05 第一三共株式会社 用于选择性制造抗体-药物缀合物的方法
JP7097885B2 (ja) * 2016-12-12 2022-07-08 ベクトン・ディキンソン・アンド・カンパニー 水溶性ポリマー色素
RU2731211C1 (ru) 2017-03-21 2020-08-31 Фуджифилм Корпорэйшн Пептидное соединение и способ его получения, композиция для скринингового использования и способ отбора пептидного соединения
WO2019013707A1 (en) * 2017-07-11 2019-01-17 Agency For Science, Technology And Research MIMETALS OF GLYCOSAMINOGLYCAN PENETRATING CELLS
JP2019172826A (ja) 2018-03-28 2019-10-10 富士フイルム株式会社 蛍光性化合物及びこれを用いた蛍光標識生体物質
JP7064583B2 (ja) 2018-06-01 2022-05-10 富士フイルム株式会社 蛍光性化合物及びこれを用いた蛍光標識生体物質
EP3916000B1 (en) 2019-02-28 2026-04-08 FUJIFILM Corporation Method for producing peptide compound, protecting group-forming reagent, and aromatic heterocyclic compound
JP7344982B2 (ja) 2019-11-21 2023-09-14 富士フイルム株式会社 化合物及びこれを用いた蛍光標識生体物質
WO2022025210A1 (ja) 2020-07-30 2022-02-03 富士フイルム株式会社 化合物及びこれを用いた標識生体物質
JP7550076B2 (ja) * 2021-02-26 2024-09-12 富士フイルム株式会社 蛍光色素及びこれを用いた標識生体物質
JP7748830B2 (ja) 2021-08-20 2025-10-03 伊藤ハム株式会社 フライ食品の製造方法

Also Published As

Publication number Publication date
US20250389724A1 (en) 2025-12-25
EP4674861A1 (en) 2026-01-07
CN120752249A (zh) 2025-10-03
WO2024181455A1 (ja) 2024-09-06

Similar Documents

Publication Publication Date Title
BR102022025291A2 (https=)
JPWO2024181455A1 (https=)
BR102022023461A2 (https=)
BR102022017795A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BY13159U (https=)
BY13155U (https=)
CN307048390S (https=)
BY13141U (https=)
CN307045507S (https=)
CN307045359S (https=)
CN307044744S (https=)
CN307044566S (https=)
CN307044438S (https=)
BY23965C1 (https=)
BY13168U (https=)
BY13165U (https=)
BY13164U (https=)
BY13163U (https=)
BY13162U (https=)
BY13161U (https=)
BY13160U (https=)
CN307049235S (https=)